An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, X-linked disease, connective tissue disorder, cutaneous mucinosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inherited neurodegenerative disorder, intellectual disability, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 2, nervous system disorder	Active, not recruiting	Phase 2 / Phase 3	2026-09-03		NCT04348136

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
JCR Pharmaceuticals Co., Ltd.	8

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Hiroshima Prefectural Hospital	Hiroshima	Japan	12
Kananagawa Ckinical site	Kanagawa	Japan	1